These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 18413317)

  • 41. Intervention study of the association of antibiotic utilization measures with control of extended-spectrum beta-lactamase (ESBL)-producing bacteria.
    Wen Z; Wei X; Xiao Y; Xue F; Hao F; Zhu Y; Ma N; Xiao Y; Wang H
    Microbes Infect; 2010 Sep; 12(10):710-5. PubMed ID: 20457272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital.
    Ktari S; Arlet G; Mnif B; Gautier V; Mahjoubi F; Ben Jmeaa M; Bouaziz M; Hammami A
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4198-201. PubMed ID: 17015633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU.
    Meyer E; Lapatschek M; Bechtold A; Schwarzkopf G; Gastmeier P; Schwab F
    Intensive Care Med; 2009 May; 35(5):862-70. PubMed ID: 19034426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical sources and prevalence of resistance to antimicrobials of Klebsiella pneumoniae strains in Trinidad.
    Orrett FA
    Saudi Med J; 2005 Nov; 26(11):1766-70. PubMed ID: 16311663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.
    Landman D; Bratu S; Kochar S; Panwar M; Trehan M; Doymaz M; Quale J
    J Antimicrob Chemother; 2007 Jul; 60(1):78-82. PubMed ID: 17490999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of extended-spectrum beta-lactamases-producing isolates over a 1-year period at a University Hospital in Oman.
    Rafay AM; Al-Muharrmi Z; Toki R
    Saudi Med J; 2007 Jan; 28(1):22-7. PubMed ID: 17206284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
    Elliott E; Brink AJ; van Greune J; Els Z; Woodford N; Turton J; Warner M; Livermore DM
    Clin Infect Dis; 2006 Jun; 42(11):e95-8. PubMed ID: 16652304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15.
    Lytsy B; Sandegren L; Tano E; Torell E; Andersson DI; Melhus A
    APMIS; 2008 Apr; 116(4):302-8. PubMed ID: 18397465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Transfer of resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases].
    Babálová M; Blahová J; Králiková K; Krcméry V; Hanzen J; Balogová O; Milosovic P
    Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):21-7. PubMed ID: 11038673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
    Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
    Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.
    Bratu S; Landman D; Haag R; Recco R; Eramo A; Alam M; Quale J
    Arch Intern Med; 2005 Jun; 165(12):1430-5. PubMed ID: 15983294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 2-year trend of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Thailand: an alert for infection control.
    Kiratisin P; Chattammanat S; Sa-Nguansai S; Dansubutra B; Nangpatharapornthawee P; Patthamalai P; Tirachaimongkol N; Nunthanasup T
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):460-4. PubMed ID: 18359054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.
    Landman D; Babu E; Shah N; Kelly P; Olawole O; Bäcker M; Bratu S; Quale J
    J Antimicrob Chemother; 2012 Jun; 67(6):1427-31. PubMed ID: 22378678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Lin JC; Siu LK; Fung CP; Yeh KM; Chang FY
    J Clin Microbiol; 2007 Jan; 45(1):266-9. PubMed ID: 17093025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
    Shah PM
    Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.
    Ko KS; Lee MY; Song JH; Lee H; Jung DS; Jung SI; Kim SW; Chang HH; Yeom JS; Kim YS; Ki HK; Chung DR; Kwon KT; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):453-9. PubMed ID: 18482815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea.
    Lee H; Yong D; Yum JH; Roh KH; Lee K; Yamane K; Arakawa Y; Chong Y
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):305-12. PubMed ID: 16822637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults.
    Oteo J; Cuevas O; López-Rodríguez I; Banderas-Florido A; Vindel A; Pérez-Vázquez M; Bautista V; Arroyo M; García-Caballero J; Marín-Casanova P; González-Sanz R; Fuentes-Gómez V; Oña-Compán S; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Sep; 64(3):524-8. PubMed ID: 19525516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
    Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
    Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.